Navigation Links
Discounted Global Pharma & Biotech Market Research Study by MP Advisors Published at MarketPublishers.com
Date:11/25/2013

London, UK (PRWEB) November 25, 2013

In the next few years, the world of medicine is expected to see a hike in the approval of innovative pharmaceuticals which are poised to introduce a range of great improvements in the standard of care (SOC). Such therapy fields as oncology, ophthalmology, diabetes, hepatitis C infection, dyslipidemia, multiple sclerosis (MS), atrial fibrillation (AF), melanoma and Alzheimer’s disease (AD) represent the areas where newer safer, more efficacious therapies will mostly likely reach the marketplace. Thus, in 2012, a great many new blockbuster drugs’ approvals took place.

In the short run, the pharma business is likely to remain highly attractive as factors such as cost containment incentives, deconsolidation/restructuring, share repurchase programmes, mergers and acquisitions, emerging market growth prospects and dividend policy keep on being encouraging. In the years ahead, the industry growth pattern is forecast to be determined by the fight between key growth drivers like value added innovation and regulations to hold back costs.

Discounted market research report “Global Pharmaceutical & Biotechnology Outlook 2013: Global Pharma” worked out by MP Advisors is now available at MarketPublishers.com.

Report Details:

Title: Global Pharmaceutical & Biotechnology Outlook 2013: Global Pharma
Published: January, 2013
Pages: 131
Price: US$ 1,500.00
http://marketpublishers.com/report/life_sciences/pharmaceuticals/global-pharmaceutical-biotechnology-outlook-2013-global-pharma.html

The research report provides true and unbiased insights into the global pharma industry. The study focuses on comprehensive analyses of individual large cap companies, budding up and coming drug candidates in their late stage development pipelines, the overall competitive landscape, as well as the most important therapy areas where new innovation is set to create leadership. Additionally, the research is enriched with in extensive forecasts for key marketed drugs where competition and/or regulatory issues are likely to change the dynamics, along with discussions of the potential impact of several major upcoming milestones on the sector.

Major Topics Discussed:

  •     Comprehensive overview the global pharma industry, with a focus on value based pricing;
  •     Analysis of the prevalence, market size opportunities and competitive landscape of leading therapy classes;
  •     Thorough examination of emerging markets and their importance in the growth of global large cap pharma;
  •     Detailed discussions of the world’s large cap pharma companies, such as Merck, Novartis, Roche, Astrazeneca, Bristol-Myers Squibb, Eli Lilly, Glaxosmithkline, Novo Nordisk, and Sanofi;
  •     Impact of patent expiry in w.r.t. 2012 total revenue through 2017;
  •     Snapshot of global pharma research pipeline (PhII and PhIII) in 2013;
  •     Worldwide pharma milestones in 2013.

Other Discounted Studies by MP Advisors Include but are Not Limited to:

  •     Global Pharmaceutical & Biotechnology Outlook 2013: India Pharma
  •     Global Pharmaceutical & Biotechnology Outlook 2013: Rising Stars
  •     Global Pharmaceutical & Biotechnology Outlook 2013: Mature Biotech
  •     Global Pharmaceutical & Biotechnology Outlook 2013: Japan Pharma

For more discounted market research reports by MP Advisors please click here.

Read the full story at http://www.prweb.com/releases/2013/11/prweb11366796.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. 4leafcity.com: Best Men’s Leather Jackets Now Available At Discounted Prices
2. Men’s Coats And Jackets From 4leafcity.com Are Now Offered At Discounted Prices
3. ClearPores Acne Cleansing System is now available at a discounted price up to 25%
4. Discounted Snow White Wedding Dresses Available At iFitDress.com
5. Discounted Wood Caskets For November Now at MillionaireCasket.com
6. Weekend Sale Launched by OgotoShop.com, Greatly Discounted Holiday Dresses for 2013 and 2014
7. Regency Wedding Dresses At Discounted Prices Now Reported Online At iFitDress.com
8. One Of The World’s Leading Chocolate Molds Wholesalers, TOGOHK.com, Announces Discounted Prices On Its Chocolate Molds
9. Matrix Spa & Massage Announce a Special Discounted Rate On Their Couples Massage Package
10. 2013 iHeart Radio Music Festival Tickets: Cheap Concert Tickets Announces that Discounted Tickets for the 3rd Annual iHeart Radio Music Festival Go Onsale July 20th
11. Affordable Bon Jovi Tickets: BuyCheapTicketsToEvents.com Releases Additional Inventory of Discounted Seats for Bon Jovi's Upcoming Concerts
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/24/2017)... , ... April 24, 2017 , ... ... designed to recognize elevated anxiety levels in people with addiction who are served ... Smart Patch, a biosensing wearable device that monitors heart and breath rates to ...
(Date:4/24/2017)... ... April 24, 2017 , ... Labs often perform the ... for lab operators and management to assess these processes with a critical eye—particularly ... unnecessary actions. , Created with the help of both internal and external ...
(Date:4/24/2017)... ... ... “The Saint with Trin, and Omega Station”: a triple feature offering nonstop action ... author, Chris Jackson. Chris Jackson grew up in Abilene, Texas. He now ... teaching English. He is heavily involved in the youth group of his local church. ...
(Date:4/24/2017)... ... , ... A 2-in-1 bottleless water appliance provides both purified ... Texas, here are the ways in which this technology can benefit dental offices: ... fresh, oxygenated water, with both cold and hot options. , Convenience for Dentists ...
(Date:4/22/2017)... NY (PRWEB) , ... April 22, 2017 , ... ... which shows that U.S. consumers can save an average of 70% when buying ... savings (up to 97%) are available when purchasing from other countries. The report ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... 20, 2017 NeuroVive Pharmaceutical AB (Nasdaq ... positive preclinical results demonstrating anti-fibrotic effects with ... steatohepatitis (NASH), in an additional well-validated experimental ... has previously shown similar anti-fibrotic effects in ... scientists present novel data demonstrating anti-fibrotic effects ...
(Date:4/19/2017)... , April 19, 2017  IRIDEX Corporation (Nasdaq: ... release financial results for the first quarter 2017 after ... The Company,s management team will host a corresponding conference ... ET. Investors interested in listening to the ... for domestic callers or (703) 326-3030 for international callers, ...
(Date:4/19/2017)... SAN DIEGO , April 19, 2017 /PRNewswire/ ... ("Sorrento"), an antibody-centric, clinical-stage biopharmaceutical company developing new ... today announced the closing of its previously announced ... common stock at a public offering price of ... commissions and estimated offering expenses payable by Sorrento.  ...
Breaking Medicine Technology: